Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy

NCT01061970 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Fispemifene

Sponsor

QuatRx Pharmaceuticals Company